Who is a good candidate for it?

Good candidates include patients with moderate to severe active inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis, who have not responded adequately to conventional therapies like corticosteroids or immunomodulators. Contraindications include active infections (e.g., tuberculosis, hepatitis B), a history of demyelinating disorders, moderate to severe heart failure, or known hypersensitivity to anti-TNF agents. A thorough pre-treatment screening, including TB testing and liver function assessment, is mandatory to confirm suitability.